-
Adobe Ideas is an easy-to-master, vector-based tool for drawing.
ENGADGET: Adobe brings Touch Apps family to Android tablets, Creative Cloud looms on the horizon
-
Van Gogh based it on a drawing by Gauguin.
ECONOMIST: Van Gogh and Gauguin: Sunny side down | The
-
This is despite the government body that advises on security, based at GCHQ in Cheltenham, drawing up standards for validating the security, or otherwise, of the meters.
BBC: How to hack a nation's infrastructure
-
Yuan-based "dim sum" bonds are drawing global investors these days for their higher yields, not merely as a bet that the Chinese currency will rise.
WSJ: What's News
-
The technique was based on a gestural vocabulary that included drawing back, with both hands open and raised up, eyes wide open, and mouth agape, to indicate surprise, and that sort of thing.
FORBES: Why You Need to Change Your Public Speaking Style
-
Her calculation involves some new math, based on the belief that her survival depends on drawing into the primaries some moderates and independents and women like Toni Pappas, who jumped from her seat and cheered, "You go, girl!"
CNN: Elizabeth unplugged
-
And I think the expectation on the part of both ourselves and our partners in the coalition is that as the Afghans increase their capability, then we can move to more challenging parts of the country and at the same time all of us begin drawing down our forces, again, based on conditions on the ground.
WHITEHOUSE: Press Briefing on Afghanistan-Pakistan Annual Review
-
The movie is based on a novel of the same name, and it is drawing praise from critics across the country.
NPR: 'Mysterious Skin' Chronicles the Aftermath of Abuse
-
There's a small included stylus that slots in at the top of the screen (or the bottom, the screen auto-flips vertically based on how you hold the device) but while the stylus is fun for drawing notes, all you really need is a light tap or swipe with your fingers to operate the device.
ENGADGET: iriver Story Touch Edition preview
-
Paris-based Sanofi-Synthelabo (nyse: SNY - news - people ) was sent back to the drawing board and returned with a trial that took a more conservative approach, asking for approval only as a second-line medicine.
FORBES: Magazine Article